The Problem With Most CBD Products
The cannabinoid wellness industry has a standardization problem — and the data is unambiguous.
A landmark 2017 study published in JAMA by Bonn-Miller et al. analyzed 84 CBD products purchased online and found that only 31% were accurately labeled. Of the remaining 69%: 43% were underlabeled (contained more CBD than claimed) and 26% were overlabeled (contained less CBD than claimed). THC was detected in 21% of products at levels sufficient to produce psychoactive effects or trigger a positive drug test.
A follow-up 2015 study by Vandrey et al., also published in JAMA, found similar labeling inaccuracies in edible cannabis products, with cannabinoid concentrations varying by as much as 50% from label claims.
This is not a fringe problem. It is an industry-wide quality failure rooted in the absence of mandatory standardization requirements for hemp-derived cannabinoid products in the United States.
What Standardization Actually Means
In pharmaceutical and nutraceutical science, standardization refers to the process of ensuring that a product contains a consistent, verified concentration of its active ingredient(s) across every batch produced. A standardized product delivers the same dose of the same compound every time — regardless of when it was manufactured, which raw material lot was used, or which production run it came from.
For cannabinoid products, standardization means:
- Consistent cannabinoid concentrations — the mg of CBD, CBG, CBN, or CBC per ml matches the label claim within an acceptable tolerance across every batch
- Batch-to-batch reproducibility — the formulation performs the same way across production runs, not just in a single reference batch
- Verified by independent testing — not self-reported by the manufacturer, but confirmed by an ISO/IEC 17025-accredited third-party laboratory
- Full-panel safety testing — potency verification alone is insufficient; heavy metals, pesticides, residual solvents, and microbials must also be tested and published
Why Most Products Fail This Standard
Achieving true standardization requires significant investment in raw material quality control, in-process testing, finished product testing, and formulation expertise. Most brands in the cannabinoid space are white-label operations — they purchase pre-made extracts from contract manufacturers and apply their own label. In this model, the brand has limited visibility into the formulation process and limited ability to control batch-to-batch consistency.
Even brands that manufacture their own products often rely on a single Certificate of Analysis (COA) from a single batch to represent an entire product line — a practice that does not constitute standardization. A single COA proves one batch was tested. It says nothing about the batch you actually purchased.
How to Verify Standardization Before You Buy
The only way to verify that a cannabinoid product is standardized is to examine batch-specific COAs from an accredited laboratory. Here's what to look for:
- Batch-specific COAs — the COA must reference the specific batch or lot number of the product you purchased, not a generic sample or a single reference batch
- ISO/IEC 17025 accreditation — the testing laboratory must hold this international accreditation, which ensures methodological rigor, result reliability, and independence from the manufacturer
- Full-panel testing — the COA must cover cannabinoid potency, heavy metals (lead, arsenic, mercury, cadmium), pesticides, residual solvents, and microbials
- Consistent results across multiple batches — if a brand publishes multiple COAs, compare cannabinoid concentrations across batches to assess true reproducibility
- No selective disclosure — a brand that only publishes passing results is not practicing radical transparency; look for brands that commit to publishing all results
Frequently Asked Questions
What does standardized CBD mean?
A standardized CBD product contains a verified, consistent concentration of cannabinoids in every batch — confirmed by independent, accredited laboratory testing. It means the dose on the label matches what's in the bottle, every time.
How do I know if a CBD product is standardized?
Request or locate the batch-specific Certificate of Analysis (COA) for the product you purchased. The COA should be issued by an ISO/IEC 17025-accredited laboratory and reference your specific batch number. Compare results across multiple batches if available.
Why do CBD products have inconsistent potency?
Most CBD products are white-labeled from contract manufacturers with limited quality control. Without mandatory standardization requirements, brands can sell products with significant potency variance without legal consequence. The 2017 JAMA study found 69% of online CBD products were mislabeled.
cbdDR's Standardization Standard
Standardization is the founding principle of cbdDR. Matthew Scott built this company in 2014 specifically because the market lacked formulations that could be trusted to deliver consistent, verified cannabinoid concentrations. Every cbdDR formulation is engineered to a defined cannabinoid specification, tested by ISO/IEC 17025-accredited laboratories, and published in our Batch Database — batch by batch, not product by product.
We do not release a batch for sale if it fails any testing parameter. We do not selectively publish results. And we do not white-label — every formulation is our own, developed in-house by a botanical scientist with over a decade of cannabinoid formulation experience.
Standardization is not a marketing claim. It is a verifiable commitment. We invite you to verify ours.
Related Articles
- The Endocannabinoid System: How Your Body Regulates Itself
- Broad Spectrum vs. CBD Isolate: A Scientific Comparison
- What Is Broad Spectrum CBD? A Complete Science-Based Guide
- View cbdDR Batch Database — All COAs Published
References
- Bonn-Miller MO, et al. (2017). Labeling Accuracy of Cannabidiol Extracts Sold Online. JAMA, 318(17), 1708–1709. PMID: 29114823
- Vandrey R, et al. (2015). Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products. JAMA, 313(24), 2491–2493. PMID: 26103034
- ISO/IEC 17025:2017. General requirements for the competence of testing and calibration laboratories. International Organization for Standardization.
- U.S. Hemp Authority. (2020). Certified Good Manufacturing Practices for Hemp Products.
cbdDR does not make disease treatment claims. All formulations are hemp-derived and federally legal under the 2018 Farm Bill. Consult a qualified healthcare provider for medical advice.